default author photo

Rachel Bruton

University of Birmingham - Institute of Immunology and Immunotherapy

Birmingham

United Kingdom

  • University of Birmingham - Institute of Immunology and Immunotherapy

SCHOLARLY PAPERS

7

DOWNLOADS
Rank 19,015

SSRN RANKINGS

Top 19,015

in Total Papers Downloads

6,437

TOTAL CITATIONS

23

Scholarly Papers (7)

Actions:
Email selected abstracts
1.

Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1

Number of pages: 15 Posted: 13 Apr 2021
Helen Marie Parry, Rachel Bruton, Gokhan Tut, Myah Ali, C Stephens, Sian Faustini, A Huissoon, R Meade, Kevin Brown, Gayatri Amirthalingam, Bassam Hallis, Alex G. Richter and Jianmin Zuo
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Clinical Immunology Service, University Hospitals Birmingham NHS Foundation Trust, Harborne Medical Practice, Public Health England, Public Health England - Immunisation and Countermeasures Division, Public Health England - National Infection Service, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 4,474 (5,526)
Citation 12

Abstract:

Loading...

Vaccination, SARS-CoV-2, COVID, Antibody, Cellular, mRNA, ChAdOx1

2.

Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukaemia

Number of pages: 23 Posted: 25 May 2021
Helen Marie Parry, Graham McIlroy, Rachel Bruton, Myah Ali, Christine Stephens, S. Damery, Ashley Otter, Tina McSkeane, Hayley Rolfe, Sian Faustini, Nadezhda Wall, P. Hillmen, Guy Pratt, Shankara Paneesha, Jianmin Zuo, Alex G. Richter and Paul Moss
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Applied Health Research, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Immunology and Immunotherapy, Leeds Teaching Hospitals NHS Trust - St. James’s University Hospital, University Hospitals Birmingham - Queen Elizabeth Hospital, University Hospitals Birmingham - Birmingham Heartlands Hospital, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 1,105 (49,159)
Citation 6

Abstract:

Loading...

Vaccination; CLL; Leukaemia; SARS-CoV-2; COVID; Antibody

3.

Booster Vaccination Strongly Enhances SARS-CoV-2-Specific Antibody and Cellular Responses in Elderly Residents of Care Homes

Number of pages: 20 Posted: 20 Dec 2021
Gokhan Tut, Tara Lancaster, Maria Krutikov, Panagiota Sylla, David Bone, Eliska Spalkova, Christopher Bentley, Umayr Amin, Azar Jadir, Samuel Hulme, Nayandeep Kaur, Elif Tut, Rachel Bruton, Rebecca Giddings, Madhumita Shrotri, Borscha Azmi, Chris Fuller, Verity Baynton, Aidan Irwin-Singer, Andrew C Hayward, Andrew Copas, Laura Shallcross and Paul Moss
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 261 (291,839)
Citation 3

Abstract:

Loading...

SARS-CoV-2, COVID-19, Vaccination, Booster, Care home, Long Term Care Facility (LTCF), Elderly

4.

Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic Leukaemia

Number of pages: 26 Posted: 12 Oct 2021
Helen Marie Parry, Graham McIlroy, Rachel Bruton, Sarah Damery, Grace Tyson, Nicola Logan, Chris Davis, Brian Willett, Jianmin Zuo, Myah Ali, Manjit Kaur, Christine Stephens, Dawn Brant, Ashley Otter, Tina McSkeane, Hayley Rolfe, Sian Faustini, Alex G. Richter, Sophie Lee, Farooq Wandroo, Salim Shafeek, Guy Pratt, Shankara Paneesha and Paul Moss
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham, UK Health Security Agency - Rare & Imported Pathogens Laboratory, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Cancer Research UK Clinical Trials Unit, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences, Government of the United Kingdom - Royal Wolverhampton NHS Trust, Barking, Havering and Redbridge University Hospitals NHS Trust - Sandwell and West Birmingham Hospitals NHS Trust, Herefordshire and Worcestershire Health and Care NHS Trust, University Hospitals Birmingham NHS Foundation Trust, University Hospitals Birmingham - Birmingham Heartlands Hospital and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 196 (387,924)

Abstract:

Loading...

CLL, COVID-19, SARS-CoV-2, Vaccination

5.

Profile of Humoral and Cellular Immune Responses to Single BNT162b2 or ChAdOx1 Vaccine in Residents and Staff Within Residential Care Homes (VIVALDI Study)

Number of pages: 17 Posted: 04 May 2021
Gokhan Tut, Tara Lancaster, Maria Krutikov, Panagiota Sylla, David Bone, Nayandeep Kaur, Eliska Spalkova, Christopher Bentley, Umayr Amin, Azar Jadir, Samuel Hulme, Megan Butler, Morenike Ayodele, Rachel Bruton, Madhumita Shrotri, Borscha Azmi, Chris Fuller, Aidan Irwin-Singer, Andrew C Hayward, Andrew Copas, Laura Shallcross and Paul Moss
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - UCL Institute of Health Informatics, University College London - Institute for Health Informatics, University College London - UCL Institute of Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 188 (403,391)
Citation 2

Abstract:

Loading...

6.

Reduced Antibody and Cellular Immune Responses Following Dual COVID-19 Vaccination Within Infection-Naïve Residents of Long-Term Care Facilities

Number of pages: 29 Posted: 09 Dec 2021
Gokhan Tut, Tara Lancaster, Megan S. Butler, David Bone, Nayandeep Kaur, Eliska Spalkova, Christopher Bentley, Panagiota Sylla, Umayr Amin, Azar Jadir, Samuel Hulme, Morenike Ayodele, Duncan Murray, David Greenwood, Wayne Croft, Elif Tut, Rachel Bruton, Maria Krutikov, Rebecca Giddings, Madhumita Shrotri, Borscha Azmi, Chris Fuller, Aidan Irwin-Singer, Andrew C Hayward, Andrew Copas, Laura Shallcross and Paul Moss
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, University College London - Institute for Health Informatics, UK Health Security Agency, Health Data Research UK, University College London - Institute for Global Health, University College London - Institute for Health Informatics and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 187 (405,402)

Abstract:

Loading...

Long Term Care Facility, Resident, COVID-19, SARS-CoV-2, Vaccination

7.

Vaccine Subtype and Dose Interval Determine Immunogenicity of Primary Series COVID-19 Vaccines in Older People

Number of pages: 29 Posted: 27 Apr 2022
Helen Parry, Rachel Bruton, Morenike Ayodele, Panagiota Sylla, Graham McIlroy, Nicola Logan, Sam Scott, Sam Nicol, Kriti Verma, Christine Stephens, Brian Willett, Jianmin Zuo and Paul Moss
University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Cancer and Genomic Sciences, University of Glasgow - Centre for Virus Research (CVR), University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Birmingham - Institute of Immunology and Immunotherapy, University of Glasgow - Centre for Virus Research (CVR), University of Birmingham - Institute of Immunology and Immunotherapy and University of Birmingham - Institute of Immunology and Immunotherapy
Downloads 26 (1,372,601)

Abstract:

Loading...

COVID-19, vaccines, elderly, primary series, BNT162b2, ChAdOx1